 Perioperative blood transfusion prognosis patients stage lung cancer blood transfusion prognosis cancer patients immunosuppression affect advanced disease hypothesis patients stage lung cancer Mean median follow-up months months Patients postoperative period Perioperative transfusion administration whole blood packed cells days operation overall cumulative disease-free survival rate patients transfusion patients transfusion multivariate analysis patient age race sex cell type extent operation pneumonectomy versus lobectomy/segmentectomy operative blood loss admission hematocrit discharge hematocrit presence absence perioperative transfusion variable disease-free survival presence absence perioperative transfusion effect number transfusions Retrospective analysis long-term results patients curative operation stage cancer shows perioperative transfusion patient prognosis association due adverse effect transfusion transfusion marker risk factor